Avexxin (private company)
See something wrong or missing? Let us know
Offices:Trondheim
Industry:Health servicesPharma
Business model:B2B
Avexxin will provide a new generation of therapeutics treating serious medical conditions associated with chronic inflammatory disorders and specific cancers.
Investors:
we tracked 3 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Avexxin
Name | Criteria | |
---|---|---|
![]() |
Cinclus Pharma
55%
|
|
![]() |
Pharmedigroup
55%
|
|
![]() |
Synapse Medicine
55%
|
|
![]() |
Trialbee
55%
|
|
![]() |
Causaly
55%
|
|
![]() |
PEP-Therapy
55%
|
|
![]() |
iCellate
52%
|
|
![]() |
Pila Pharma
52%
|
|
![]() |
Beckley Psytech
50%
|
|
![]() |
Octarine Bio
50%
|
|